Understanding clinical outcomes and factors influencing mortality in intensive care unit patients with COVID-19-associated candidemia.
Selda AydınAli MertMesut YılmazMuna Al MaslamaniBilal Ahmad RahimiFolusakin AyoadeAmani El-KholyMaya BelitovaBuket Ertürk SengelSabah JalalAyşe AlbayrakJamayel Adnan AlatawiBalint Gergely SzaboRamesh Shankar GaneshanEmmanuel NsutebuAruna PoojaryYasemin AkkoyunluSevil AlkanDilşah Başkol ElikGulden Eser-KarlidagLurdes SantosRuxandra MorotiNilgün AltınEsra GürbüzTülay Ünver UlusoyOğuz Reşat SipahiHülya ÇaşkurluAliye EsmaoğluBotond LakatosNagwa Mostafa El-SayedAndrea MarınoAntonio CascioAlexandru MihaiIrina Magdalena DumitruNatalia PshenichnayaRezaul Karim RiponMateja Jankovic MakekNaveed RashidRusmir BaljićCosmin DascaluGülden SincanYeşim Uygun KızmazBerk MadendereHakan ErdemPublished in: Mycoses (2024)
By recognising these prognostic factors, medical professionals can customise their treatment approaches to offer more targeted care, leading to improved patient outcomes and higher survival rates for individuals with COVID-associated candidemia.